Home
  • 關於疾病
    • 糖尿病足成因
    • 糖尿病足症狀
    • 糖尿病足併發症
    • 糖尿病足治療
    • 預防糖尿病足
    • 衛教手冊下載
  • 選擇速必一
    • 藥品開發過程
    • 藥品臨床試驗
    • 藥品作用機制
    • 文獻資料
    • 品質認證
  • 開始使用速必一
    • 適應症與用法用量
    • 藥物安全提醒
    • 仿單下載
    • 建議使用影片
  • 故事
    • 熱門文章
    • 熱門影音
  • 關於合一
    • 公司簡介
    • 核心價值與經營理念
    • 企業永續責任
  • 聯絡我們
  • 繁
  • 简
  • EN

文獻資料

2024-9-5
Mary Ann Liebert
Effects of ON101 for Hard-to-Heal Diabetic Foot Ulcers in a Randomized Phase III Trial: A Post Hoc Analysis
2024-7-25
中華內分泌代謝雜誌
期刊發表
糖尿病足潰瘍創面治療專家共識(2024)
2024-6-19
The Journal of Taiwan Society of Plastic Surgery
期刊發表
Efficacy of ON101 cream, a Topical Macrophage-Regulating Cream, against Chronic Burn Wounds—A Case Report and Literature Review
2024-5-28
Case Reports in Clinical Medicine
期刊發表
ON101 Cream Increases the Wound Healing Rate in Diabetic Patients with Uremia—Cases Report
2023-01-13
JAMA Network Open
期刊發表
Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector Perspective
2023-01-10
Aesthetic Surgery Journal
期刊發表
Validation of Fespixon in Postoperative Scar Cosmesis Using Quantitative Digital Photography Analysis
2022-12-28
Annals of Case Reports
期刊發表
Macrophage-Regulating Drug Treatment Promotes Tissue Proliferation in a Diabetic Foot Ulcer Patient with Exposed Anterior Tibialis Tendon - A Case Report
2022-09-27
Pharmaceutics
期刊發表
New Horizons of Macrophage Immunomodulation in the Healing of Diabetic Foot Ulcers
  • ‹
  • 1
  • 2
  • ›
Home
icon 地址:台北市中正區忠孝西路一段66號35樓
icon 電話:02-2703-1098
icon 傳真:02-2703-1200
icon Facebook
icon 聯絡我們
icon Linkedln
隱私權聲明 Copyright © Oneness Biotech Co., Ltd.. All Rights Reserved.